CRAFFT Screening Test
The CRAFFT Screening Test is a behavioral health screening tool designed for use with children and adolescents under the age of 21. It is intended to identify individuals who may have problematic use of alcohol or other drugs. The name CRAFFT is an acronym of the first letters of key words in the six screening questions.
History[edit]
The CRAFFT Screening Test was developed by the Center for Adolescent Substance Abuse Research (CeASAR) at Boston Children's Hospital. It was first introduced in 1999 and has since been widely adopted in various healthcare settings.
Methodology[edit]
The CRAFFT Screening Test consists of six questions that are designed to be self-administered by the patient. The questions are related to the use of alcohol or drugs during the past 12 months. Each "yes" response scores one point, and a total score of two or more is considered positive for a high risk of substance-related problems and disorders.
Effectiveness[edit]
Numerous studies have demonstrated the effectiveness of the CRAFFT Screening Test in identifying adolescents at risk for substance use disorders. It has been found to have good sensitivity and specificity for detecting substance use disorders in adolescents.
Limitations[edit]
While the CRAFFT Screening Test is a valuable tool for screening adolescents for substance use disorders, it is not a diagnostic tool. A positive screen should be followed by a more comprehensive assessment to confirm the diagnosis and determine the severity of the problem.
See also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian